The STC2 is positively correlated with TMB including CESC, acute myeloid leukemia (LAML), LUAD, prostate adenocarcinoma (PRAD), READ, THYM and negatively correlated with BRCA, and THCA (Figure 2B). Here, STC2 is linked to prostate adenocarcinoma.